Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soon Ae, Shim, Woo Ho, Lee, Eun Hae, Lee, Young Mi, Beom, Sun Hee, Kim, Eun Sook, Yoo, Jeong Seon, Nam, Ji Sun, Cho, Min Ho, Park, Jong Suk, Ahn, Chul Woo, Kim, Kyung Rae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122893/
https://www.ncbi.nlm.nih.gov/pubmed/21738898
http://dx.doi.org/10.4093/dmj.2011.35.2.159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122893/
https://www.ncbi.nlm.nih.gov/pubmed/21738898
http://dx.doi.org/10.4093/dmj.2011.35.2.159

Ejemplares similares